Stay updated on Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page revision metadata has been updated to v3.6.5, signaling a minor version update to the study record documentation.
    Difference
    0.1%
    Check dated 2026-08-10T11:42:08.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing the previous v3.6.3. This reflects a newer page version without changing the study details or navigation.
    Difference
    0.1%
    Check dated 2026-07-27T06:30:41.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Footer credits now display the Moffitt Cancer Center branding and the full institution name, along with a new 'Helpful Links Provided by' label, and the site revision tag was updated from v3.6.2 to v3.6.3.
    Difference
    0.2%
    Check dated 2026-07-05T12:47:31.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays a revision tag of v3.6.2, replacing the previous v3.6.0, indicating a recent site update to the page.
    Difference
    0.1%
    Check dated 2026-06-28T08:42:49.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Added recruitment-status notice 'No longer looking for participants' and new guidance sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). Updated the 'Intervention / Treatment' heading to 'Intervention/Treatment' and bumped the revision tag to v3.6.0 (removing v3.5.5).
    Difference
    0.5%
    Check dated 2026-06-13T17:32:58.000Z thumbnail image
  9. Check
    83 days ago
    Change Detected
    Summary
    The bottom revision label was updated from v3.5.4 to v3.5.5, reflecting a minor template/version update to the page. This update does not modify any study data or content on the ClinicalTrials.gov record.
    Difference
    0.1%
    Check dated 2026-06-06T14:25:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.